02/01/2006
Federal Register Notice: FDA’s Psychopharmacologic Drugs Advisory Committee will meet 3/23 from 8 a.m. to 5 p.m. at the Hilton Was...01/27/2006
Federal Register Notice: FDA has determined the regulatory review period for the extension of a patent that claims the human drug ...01/27/2006
Federal Register Notice: FDA is amending the 1/6 notice of meeting of the Oncologic Drugs Advisory Committee to change the date of...01/25/2006
Federal Register Notice: FDA is making available several proposed and final documents that have been prepared by Study Groups 1, 2...01/25/2006
Federal Register Notice: FDA’s proposed collection of information, "Export of FDA Regulated Products — Export Certificates," has b...01/25/2006
Federal Register Notice: FDA has submitted a proposed collection of information, "Blood Establishment Registration and Product Lis...01/19/2006
Federal Register Notice: FDA is withdrawing approval of 43 ANDAs held by Able Laboratories, Inc. because the drug products are no ...01/12/2006
Federal Register Notice: FDA has determined that two drug products — Celestone Soluspan (betamethasone sodium phosphate and betame...